Danimer Scientific, Inc.
NYSE:DNMR
0.3847 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 46.684 | 53.218 | 58.749 | 47.333 | 32.344 | 30.454 |
| Cost of Revenue
| 82.636 | 63.632 | 57.865 | 35.876 | 21.237 | 19.209 |
| Gross Profit
| -35.952 | -10.414 | 0.884 | 11.457 | 11.107 | 11.245 |
| Gross Profit Ratio
| -0.77 | -0.196 | 0.015 | 0.242 | 0.343 | 0.369 |
| Reseach & Development Expenses
| 21.44 | 31.939 | 20.27 | 7.851 | 5.482 | 5.136 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 7.258 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0.1 |
| SG&A
| 67.793 | 81.589 | 80.004 | 19.343 | 16.027 | 7.358 |
| Other Expenses
| 0.001 | 0.723 | -0.044 | -0.031 | 0.277 | 0 |
| Operating Expenses
| 89.233 | 113.528 | 100.274 | 27.194 | 21.509 | 8.106 |
| Operating Income
| -125.185 | -187.434 | -99.39 | -15.737 | -10.402 | -1.192 |
| Operating Income Ratio
| -2.682 | -3.522 | -1.692 | -0.332 | -0.322 | -0.039 |
| Total Other Income Expenses Net
| -29.969 | 6.866 | 26.05 | 3.164 | -5.027 | 1.451 |
| Income Before Tax
| -155.154 | -180.568 | -73.34 | -12.573 | -15.429 | 0.259 |
| Income Before Tax Ratio
| -3.323 | -3.393 | -1.248 | -0.266 | -0.477 | 0.009 |
| Income Tax Expense
| 0.319 | -0.81 | -13.233 | 2.396 | 4.085 | 0.051 |
| Net Income
| -155.473 | -179.758 | -60.107 | -14.969 | -19.514 | 0.208 |
| Net Income Ratio
| -3.33 | -3.378 | -1.023 | -0.316 | -0.603 | 0.007 |
| EPS
| -1.52 | -1.78 | -0.65 | -0.18 | -0.77 | 0.07 |
| EPS Diluted
| -1.52 | -1.78 | -0.65 | -0.18 | -0.77 | 0.07 |
| EBITDA
| -96.127 | -48.23 | -88.8 | -10.298 | -4.164 | 2.346 |
| EBITDA Ratio
| -2.059 | -0.906 | -1.512 | -0.218 | -0.129 | 0.077 |